| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/25-1/100 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 1/5000-1/10000 | Human,Mouse,Rat |
| Aliases | DMGDHD; ME2GLYDH |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Synthetic peptide of human DMGDH |
| Formulation | Purified antibody in PBS with 0.05% sodium azide and 50% glycerol. |
+ +
关于DMGDH(二甲基甘氨酸脱氢酶)抗体的研究文献相对较少，以下是基于学术数据库的示例性文献(部分为虚构示例，实际引用请核实)：
1. **文献名称**: "Production and characterization of a monoclonal antibody against human dimethylglycine dehydrogenase"
**作者**: Tanaka K, et al.
**摘要**: 该研究报道了一种针对人源DMGDH的单克隆抗体的制备，验证了其在Western blot和免疫组化中的特异性，并用于分析DMGDH在肝脏组织中的线粒体定位。
2. **文献名称**: "Dimethylglycine dehydrogenase deficiency: Molecular analysis and antibody-based detection"
**作者**: Smith J, et al.
**摘要**: 研究通过开发兔多克隆抗体，在患者样本中检测DMGDH蛋白表达缺失，揭示了基因突变与代谢异常(如二甲基甘氨酸尿症)的关联。
3. **文献名称**: "Mitochondrial dimethylglycine dehydrogenase as a biomarker in cancer: insights from antibody-based profiling"
**作者**: Lee H, et al.
**摘要**: 利用商业化DMGDH抗体(货号：AB123.ABC公司)分析肿瘤组织，发现DMGDH在肝癌中的表达下调可能与其代谢重编程相关。
**提示**：实际研究中建议通过PubMed或Google Scholar以“DMGDH antibody”或“dimethylglycine dehydrogenase antibody”为关键词检索最新文献，并优先选择抗体开发或疾病机制相关研究。部分商业化抗体供应商(如Abcam、Sigma-Aldrich)的技术手册也可能提供参考文献。
**Background of DMGDH Antibody**
The **dimethylglycine dehydrogenase (DMGDH) antibody** is a tool used to study DMGDH, a mitochondrial enzyme encoded by the *DMGDH* gene in humans. DMGDH plays a critical role in the choline degradation pathway, catalyzing the oxidation of dimethylglycine (DMG) to sarcosine while releasing formaldehyde and generating reduced flavin adenine dinucleotide (FADH₂). This reaction links one-carbon metabolism to the mitochondrial electron transport chain, impacting cellular energy production and methylation processes.
DMGDH dysfunction is associated with metabolic disorders, including hypermethioninemia and hypermethylation syndromes, as well as potential links to hypertrophic cardiomyopathy and neurodegenerative diseases. Its activity is influenced by genetic variants, with mutations in *DMGDH* leading to enzyme deficiency and metabolic imbalances. Research on DMGDH also explores its role in mitochondrial health, oxidative stress, and as a biomarker for certain cancers.
The DMGDH antibody is widely used in techniques like Western blotting, immunohistochemistry, and ELISA to detect DMGDH expression and localization in tissues, particularly liver and kidney, where the enzyme is highly active. It aids in elucidating DMGDH's physiological roles, pathological mechanisms, and therapeutic potential in metabolic diseases. Antibody specificity is validated using knockout controls, ensuring accurate detection in experimental models.
×
